ProShare Advisors’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,795
Closed -$316K 2261
2022
Q1
$316K Sell
9,795
-1,191
-11% -$32.2K ﹤0.01% 1595
2021
Q4
$291K Buy
+10,986
New +$279K ﹤0.01% 1810
2021
Q3
Sell
-12,449
Closed -$328K 2363
2021
Q2
$328K Sell
12,449
-249
-2% -$6.25K ﹤0.01% 1840
2021
Q1
$283K Buy
12,698
+2,378
+23% +$54.5K ﹤0.01% 1839
2020
Q4
$202K Buy
+10,320
New +$171K ﹤0.01% 1844
2018
Q3
Sell
-6,374
Closed -$224K 1810
2018
Q2
$224K Buy
6,374
+593
+10% +$21.9K ﹤0.01% 1551
2018
Q1
$229K Sell
5,781
-678
-10% -$26.3K ﹤0.01% 1471
2017
Q4
$236K Buy
+6,459
New +$245K ﹤0.01% 1549
2014
Q4
Sell
-13,323
Closed -$213K 2177
2014
Q3
$213K Sell
13,323
-3,310
-20% -$56.1K ﹤0.01% 1946
2014
Q2
$292K Sell
16,633
-18,729
-53% -$322K ﹤0.01% 1927
2014
Q1
$606K Buy
+35,362
New +$544K 0.01% 1706
2013
Q4
Sell
-22,386
Closed -$414K 1999
2013
Q3
$414K Sell
22,386
-510
-2% -$9.22K 0.01% 1634
2013
Q2
$398K Buy
+22,896
New +$316K 0.01% 1496

Other funds holding TVTY

ProShare Advisors's TVTY Position: Q2 2022 in Review

ProShare Advisors sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 9,795 shares — an estimated $316K sold.

ProShare Advisors first reported a position in TVTY in Q2 2013 and held it in 13 quarters. The position peaked at $606K in Q1 2014. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.

  • ProShare Advisors reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • ProShare Advisors sold 9,795 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $316K.
  • ProShare Advisors first reported a position in Tivity Health, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
  • ProShare Advisors's Tivity Health, Inc. Common Stock position peaked at $606K in Q1 2014.
  • 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.

Based on ProShare Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.